Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter May 16, 2022

Effect of different incubation times on the detection of factor VIII inhibitor in acquired hemophilia A

Jiahong Zhang, Runqing Mu, Junli Chen and Jianqing Song

Corresponding author: Jianqing Song, Professor of Medicine, Department of Clinical Laboratory, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning 110001, P.R. China. E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The study was approved by the Ethics Committee of Medical Science Research of the First Hospital of China Medical University (No. [2021]517).


1. Lassila, R. Management of coagulation factor VIII (FVIII) inhibitors. Thromb Res 2019;181(1 Suppl):S60–1. in Google Scholar

2. Kruse-Jarres, R, Kempton, CL, Baudo, F, Collins, PW, Knoebl, P, Leissinger, CA, et al.. Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol 2017;92:695–705. in Google Scholar PubMed

3. Moriai, R, Yanagihara, N, Endoh, A, Yamada, S, Mochizuki, M, Kondo, T, et al.. A case of acquired hemophilia A: usefulness of various methods for judging mixing test results for monitoring the effect of immunosuppressive therapy. Clin Lab 2018;64:623–6. in Google Scholar PubMed

4. Verbruggen, B, Dardikh, M, Polenewen, R, van Duren, C, Meijer, P. The factor VIII inhibitor assays can be standardized: results of a workshop. J Thromb Haemost 2011;9:2003–8. in Google Scholar PubMed

5. Tang, N, Chen, Y, Li, D, Yin, S. Determining the cutoff value of the APTT mixing test for factor VIII inhibitor. Clin Chem Lab Med 2019;57:e88–90. in Google Scholar PubMed

6. Kershaw, G, Orellana, D. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times. Semin Thromb Hemost 2013;39:283–90. in Google Scholar PubMed

7. Favaloro, EJ. Coagulation mixing studies: utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests. Am J Hematol 2020;95:117–28. in Google Scholar PubMed

8. Coppola, A, Favaloro, EJ, Tufano, A, Di Minno, MN, Cerbone, AM, Franchini, M. Acquired inhibitors of coagulation factors: part I-acquired hemophilia A. Semin Thromb Hemost 2012;38:433–46. in Google Scholar PubMed

9. Kershaw, G, Jayakodi, D, Dunkley, S. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center. Semin Thromb Hemost 2009;35:760–8. in Google Scholar PubMed

10. Werwitzke, S, Geisen, U, Nowak-Gottl, U, Eichler, H, Stephan, B, Scholz, U, et al.. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study. J Thromb Haemost 2016;14:940–7. in Google Scholar PubMed

Received: 2022-02-20
Accepted: 2022-04-04
Published Online: 2022-05-16
Published in Print: 2022-07-26

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Scroll Up Arrow